CBX7 and hepatocellular carcinoma: According to the results of our animal experiments and analysis of human HCC datasets, CBX7 was clearly shown to inhibit (rather than enhance) liver cancer progression via targeting multiple genes, such as WNT10a, DUSP4, FGFR2, and CCNE1 [60].